Luigi Formisano Selected Research

NSC48478

7/2015

Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigi Formisano Research Topics

Disease

44	Neoplasms (Cancer) 12/2023 - 07/2011
27	Breast Neoplasms (Breast Cancer) 05/2023 - 05/2014
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2024 - 01/2013
7	Stroke (Strokes) 03/2024 - 02/2013
6	Neuroblastoma 01/2017 - 09/2011
5	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2013
5	Brain Ischemia (Cerebral Ischemia) 01/2023 - 02/2013
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 09/2015
4	Melanoma (Melanoma, Malignant) 01/2023 - 01/2018
4	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 08/2013
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 02/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015 - 01/2014
2	Cardiotoxicity 01/2023 - 06/2021
2	Adenocarcinoma 07/2022 - 09/2021
2	Obesity 01/2022 - 10/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 07/2019
2	Ischemia 12/2019 - 03/2007
2	Triple Negative Breast Neoplasms 02/2019 - 01/2016
2	Nervous System Diseases (Neurological Disorders) 10/2017 - 02/2015
2	Necrosis 10/2017 - 06/2002
2	Hypoxia (Hypoxemia) 03/2013 - 03/2008
1	Urogenital Neoplasms 12/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2023
1	Iron Overload 01/2023

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 05/2023 - 01/2017
9	Tyrosine Kinase InhibitorsIBA 05/2024 - 09/2015
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2002
8	ErbB Receptors (EGF Receptor)IBA 08/2019 - 01/2013
7	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2018
7	Letrozole (Femara)FDA LinkGeneric 01/2021 - 01/2017
6	palbociclibIBA 01/2023 - 01/2017
6	Estrogens (Estrogen)FDA Link 01/2021 - 08/2017
5	Transcription Factors (Transcription Factor)IBA 03/2024 - 06/2002
5	AlpelisibIBA 01/2023 - 01/2017
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2023 - 02/2015
5	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2017
5	RE1-silencing transcription factorIBA 01/2021 - 03/2007
5	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2021 - 08/2017
4	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2017
4	ElementsIBA 03/2024 - 03/2007
4	Fulvestrant (Faslodex)FDA Link 05/2023 - 01/2018
4	Hormones (Hormone)IBA 01/2023 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2013
4	Immune Checkpoint InhibitorsIBA 08/2022 - 09/2019
4	Gemcitabine FDA Link 07/2022 - 07/2019
4	folfirinoxIBA 07/2022 - 07/2019
4	Protein Isoforms (Isoforms)IBA 10/2020 - 03/2008
4	Mechanistic Target of Rapamycin Complex 1IBA 10/2020 - 01/2016
4	Everolimus FDA Link 11/2019 - 07/2012
4	LigandsIBA 02/2019 - 10/2017
4	Polychlorinated Biphenyls (PCBs)IBA 10/2017 - 09/2011
3	Messenger RNA (mRNA)IBA 01/2023 - 03/2007
3	Monoclonal AntibodiesIBA 06/2021 - 01/2013
3	Small Interfering RNA (siRNA)IBA 01/2021 - 10/2017
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2017
3	neratinibIBA 10/2020 - 01/2019
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 04/2015
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 12/2015
3	Cetuximab (Erbitux)FDA Link 09/2015 - 01/2013
2	Cyclin-Dependent Kinase 4IBA 05/2023 - 01/2023
2	abemaciclibIBA 05/2023 - 01/2018
2	NivolumabIBA 01/2023 - 06/2021
2	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2019
2	pembrolizumabIBA 01/2023 - 06/2021
2	130-nm albumin-bound paclitaxelIBA 07/2022 - 09/2021
2	LeptinIBA 01/2022 - 09/2012
2	AdipokinesIBA 01/2022 - 10/2013
2	Oxygen (Dioxygen)IBA 11/2021 - 02/2013
2	human ERBB2 proteinIBA 01/2021 - 05/2014
2	Histones (Histone)IBA 10/2020 - 03/2007
2	Angiogenesis InhibitorsIBA 03/2020 - 01/2018
2	MTOR InhibitorsIBA 03/2020 - 06/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 07/2011
2	pertuzumabIBA 01/2019 - 12/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2018
2	ribociclibIBA 01/2018 - 01/2017
2	Aromatase InhibitorsIBA 01/2018 - 08/2017
2	Phosphotransferases (Kinase)IBA 10/2017 - 09/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 04/2015
2	Sirtuin 1IBA 01/2017 - 11/2015
2	Lapatinib (GW572016)FDA Link 12/2015 - 05/2014
2	Sodium-Calcium ExchangerIBA 05/2015 - 02/2013
2	Chlorodiphenyl (54% Chlorine)IBA 01/2015 - 09/2011
2	sodium-calcium exchanger 1IBA 10/2014 - 01/2013
1	Methyl-CpG-Binding Protein 2IBA 03/2024
1	p21-Activated KinasesIBA 10/2023
1	GenieIBA 04/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2023
1	dabrafenibIBA 01/2023
1	trametinibIBA 01/2023
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2022
1	AntibodiesIBA 10/2022
1	Neuroprotective AgentsIBA 01/2022

Therapy/Procedure

25	Therapeutics 12/2023 - 01/2013
9	Immunotherapy 05/2024 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2017
1	Nephrectomy 05/2024